Ann Intern Med

1. SNYDER SULMASY L, Burnett JR, Carney JK, DeCamp M, et al
   Ethics and Academic Discourse, Scientific Integrity, Uncertainty, and Disinformation in Medicine: An American College of Physicians Position Paper.
   Ann Intern Med. 2024 Jul 30. doi: 10.7326/M24-0648.
   

   >> Share

   
   

   
   Antiviral Res

2. ROSALES R, McGovern BL, Rodriguez ML, Leiva-Rebollo R, et al
   Nirmatrelvir and Molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 Omicron subvariants.
   Antiviral Res. 2024 Jul 25:105970. doi: 10.1016/j.antiviral.2024.105970.
   

   >> Share

   
   
3. KONISHI K, Kusakabe S, Kawaguchi N, Shishido T, et al
   beta-d-N(4)-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus.
   Antiviral Res. 2024 Jul 30:105977. doi: 10.1016/j.antiviral.2024.105977.
   

   >> Share

   
   

   
   BMJ

4. SHERWOOD O
   Covid-19 inquiry: We must not ignore the long term health impacts of covid.
   BMJ. 2024;386:q1679.
   

   >> Share

   
   
5. FEINMANN J
   Confidence among NHS staff to speak up about clinical concerns hits five year low.
   BMJ. 2024;386:q1677.
   

   >> Share

   
   
6. KUMAR A
   Words have the power to create and to destroy.
   BMJ. 2024;386:q1671.
   

   >> Share

   
   
7. O'DOWD A
   Shelving of social care cap is a tragedy, says Dilnot.
   BMJ. 2024;386:q1700.
   

   >> Share

   
   
8. KMIETOWICZ Z
   GPs and hospital doctors in England get 6% pay increase for 2024-25.
   BMJ. 2024;386:q1698.
   

   >> Share

   
   
9. MIHRANIAN OSBORNE R
   NHS England must cancel its contract with Palantir.
   BMJ. 2024;386:q1712.
   

   >> Share

   
   
10. WISE J
    Covid-19: "Substantial psychiatric burden" is still seen three years after infection, researchers find.
    BMJ. 2024;386:q1704.
    

    >> Share

    
    
11. PHELAN AL, Meier BM, Habibi R, Gostin LO, et al
    Global health reform must continue amid new infectious disease threats.
    BMJ. 2024;386:q1601.
    

    >> Share

    
    
12. MAHASE E
    Wegovy: GP pilot scheme could be scrapped after failing to launch.
    BMJ. 2024;386:q1715.
    

    >> Share

    
    
13. LIMB M
    GPs vote overwhelmingly to take collective action over contract.
    BMJ. 2024;386:q1717.
    

    >> Share

    
    
14. YAMEY G, Hoda K
    An independent panel should evaluate the health of presidential candidates.
    BMJ. 2024;386:q1716.
    

    >> Share

    
    

    
    Br J Anaesth

15. WATSON SL, Fowler AJ, Dias P, Biccard B, et al
    The lifetime risk of surgery in England: a nationwide observational cohort study.
    Br J Anaesth. 2024 Jul 30:S0007-0912(24)00394-5. doi: 10.1016/j.bja.2024.
    

    >> Share

    
    

    
    Clin Chem

16. MERRILL AE, Hackenmueller SA, Derdeyn C, Genzen J, et al
    Beyond the Screen: Navigating Remote Work within Medicine.
    Clin Chem. 2024;70:1009-1016.
    

    >> Share

    
    

    
    Int J Infect Dis

17. PEREZ-GUZMAN PN, Chanda SL, Schaap A, Shanaube K, et al
    Pandemic burden in low-income settings and impact of limited and delayed interventions: a granular modelling analysis of COVID-19 in Kabwe, Zambia.
    Int J Infect Dis. 2024 Jul 25:107182. doi: 10.1016/j.ijid.2024.107182.
    

    >> Share

    
    
18. SUN Y, Dai L, Shan Y, Yang Y, et al
    Pathogen characteristics of respiratory infections in the season after the COVID-19 pandemic between August and December 2023: evidence from direct-to-consumer testing-based surveillance in Guangzhou and Beijing, China.
    Int J Infect Dis. 2024 Jul 27:107195. doi: 10.1016/j.ijid.2024.107195.
    

    >> Share

    
    
19. THANH TT, Tu NTK, Nguyet LA, Thuy CT, et al
    Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
    Int J Infect Dis. 2024 Jul 31:107173. doi: 10.1016/j.ijid.2024.107173.
    

    >> Share

    
    
20. SHU Y, He L, Liu C
    Impact of Anti-fibrotic Medications on Post-COVID-19 Pulmonary Fibrosis: A Systematic Review and Meta-analysis.
    Int J Infect Dis. 2024 Jul 31:107193. doi: 10.1016/j.ijid.2024.107193.
    

    >> Share

    
    
21. JANGIAM W, Swangpun K, Iamsirithaworn S, Piriyasatit S, et al
    Relative vaccine effectiveness of ChAdOx1/AZD1222 vaccines as booster dose via intradermal injection with a one-fifth dose compared with the intramuscular injection in the prevention of SAR-CoV-2 infections in Phuket - A Retrospective Cohort Study.
    Int J Infect Dis. 2024 Jul 31:107179. doi: 10.1016/j.ijid.2024.107179.
    

    >> Share

    
    

    
    Intensive Care Med

22. LIU L, Sun Q, Zhao H, Liu W, et al
    Prolonged vs shorter awake prone positioning for COVID-19 patients with acute respiratory failure: a multicenter, randomised controlled trial.
    Intensive Care Med. 2024 Aug 1. doi: 10.1007/s00134-024-07545.
    

    >> Share

    
    

    
    J Infect

23. LI J, Zhang Y, Liu Z, Yang Z, et al
    Increased SARS-CoV-2 reinfection frequency, attenuated severity, and risk factor analysis in patients with hematological malignancies.
    J Infect. 2024;89:106233.
    

    >> Share

    
    

    
    J Med Virol

24. GALUCIO VCA, de Menezes DC, Chaves ECR, van den Berg AVS, et al
    Laboratory profiling of patients with long COVID in the Brazilian Amazon region: A cross-sectional study.
    J Med Virol. 2024;96:e29828.
    

    >> Share

    
    
25. LI T, Li X, Lin F, Fu H, et al
    Epidemiology of the resurgence of respiratory syncytial virus infections among children post-COVID-19: A single-center retrospective observational study.
    J Med Virol. 2024;96:e29841.
    

    >> Share

    
    

    
    J Virol

26. LI J, Zhou J, Zhang T, Wu H, et al
    Effective inhibition of PDCoV infection in chimeric APN gene-edited neonatal pigs.
    J Virol. 2024 Jul 30:e0061124. doi: 10.1128/jvi.00611.
    

    >> Share

    
    
27. ALWINE J, Goodrum F, Banfield B, Bloom D, et al
    The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence.
    J Virol. 2024 Aug 1:e0124024. doi: 10.1128/jvi.01240.
    

    >> Share

    
    
28. ZHANG Y, Wu F, Han Y, Wu Y, et al
    Unraveling the assembly mechanism of SADS-CoV virus nucleocapsid protein: insights from RNA binding, dimerization, and epitope diversity profiling.
    J Virol. 2024 Jul 31:e0092624. doi: 10.1128/jvi.00926.
    

    >> Share

    
    
29. XIAO W, Chen C, Xia S, Li Z, et al
    Cell-surface d-glucuronyl C5-epimerase binds to porcine deltacoronavirus spike protein facilitating viral entry.
    J Virol. 2024 Jul 30:e0088024. doi: 10.1128/jvi.00880.
    

    >> Share

    
    

    
    JAMA

30. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    

    >> Share

    
    

    
    Lancet

31. TRIUNFOL M
    Charges brought in Brazilian COVID-19 malpractice case.
    Lancet. 2024;404:325-326.
    

    >> Share

    
    

    
    Lancet Infect Dis

32. KEDDY KH, Gobena T
    The continuing challenge of infectious diseases.
    Lancet Infect Dis. 2024;24:800-801.
    

    >> Share

    
    
33. BISBAS G
    Reflecting on the cost of recurrent conflicts for the USA.
    Lancet Infect Dis. 2024;24:813.
    

    >> Share

    
    
34. SHERWOOD-MARTIN H
    Poor leadership or institutional flaws?
    Lancet Infect Dis. 2024;24:816.
    

    >> Share

    
    
35. TOLEDO ME, Monteagudo Diaz S, Montenegro Calderon T, Kreppel K, et al
    Preparedness for emerging epidemic threats: detection of Oropouche circulation in Cuba.
    Lancet Infect Dis. 2024;24:e484.
    

    >> Share

    
    
36. THE LANCET INFECTIOUS DISEASES
    Have we learned anything?
    Lancet Infect Dis. 2024;24:793.
    

    >> Share

    
    
37. KIRBY T
    Naomi Lucchi-from malaria to pandemic preparedness.
    Lancet Infect Dis. 2024;24:812.
    

    >> Share

    
    
38. TOLENTINO JE, Lytras S, Ito J, Holmes EC, et al
    Recombination as an evolutionary driver of MERS-related coronavirus emergence.
    Lancet Infect Dis. 2024 Jul 24:S1473-3099(24)00461.
    

    >> Share

    
    
39. KIRBY T
    Outbreaks compound Brazil's flooding disaster.
    Lancet Infect Dis. 2024;24:e490.
    

    >> Share

    
    

    
    Life Sci

40. LI B, Bai J, Xiong Y, Guo D, et al
    Understanding the mechanisms and treatments of long COVID to address future public health risks.
    Life Sci. 2024 Jul 29:122938. doi: 10.1016/j.lfs.2024.122938.
    

    >> Share

    
    

    
    N Engl J Med

41. SHAN D, Zhang G, Du Z
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477.
    

    >> Share

    
    
42. BLAIS JE
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477.
    

    >> Share

    
    
43. SHANG L, Wang Y, Cao B
    Nirmatrelvir for Adult Outpatients with Covid-19.
    N Engl J Med. 2024;391:477-478.
    

    >> Share

    
    
44. HAMMOND J, Fountaine RJ, Bao W
    Nirmatrelvir for Adult Outpatients with Covid-19. Reply.
    N Engl J Med. 2024;391:478-479.
    

    >> Share

    
    

    
    Nature

45. RAMIREZ SI, Faraji F, Hills LB, Lopez PG, et al
    Immunological memory diversity in the human upper airway.
    Nature. 2024 Jul 31. doi: 10.1038/s41586-024-07748.
    

    >> Share

    
    
46. LINDEBOOM RGH, Worlock KB, Dratva LM, Yoshida M, et al
    Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
    Nature. 2024 Aug 1. doi: 10.1038/s41586-024-07838.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share